Hum. Reprod. Advance Access originally published online on January 29, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Reproduction, Vol. 19, No. 3, 470-471,
March 2004
© 2004 European Society of Human Reproduction and Embryology
Assessment of ovarian reserve. Is there still a role for ovarian biopsy?
First do no harm!
1 Virginia Center for Reproductive Medicine, Reston, VA and 2 George Washington University, Washington, DC, 3 Reproductive Medicine Associates of New Jersey, Morristown, NJ, USA
To whom correspondence should be addressed at: 11150 Sunset Hills Road, Suite 100, Reston, VA 20190, USA. E-mail: RScott{at}rmanj.com
| Abstract |
|---|
|
|
|---|
Multiple endocrine, ultrasound-based and dynamic tests have been proposed for the assessment of ovarian reserve. Lately, ovarian biopsy has been proposed as a more representative functional test of ovarian reserve, and has been recommended as an early step in the investigation of infertility. Central to this hypothesis is the idea that a random biopsy of the ovarian cortex is reflective of the actual ovarian follicular pool. Recent studies have shown a wide variation in the number and distribution of ovarian follicles even from the same ovary and in the same patient. Coupled with the invasiveness of performing the biopsy and the risk of adhesion formation, we believe that there should not be a role for ovarian biopsy in ovarian reserve testing.
Key words: ovarian biopsy/ovarian reserve testing
| Introduction |
|---|
|
|
|---|
Since the early days of infertility testing, investigations have centred on a predictive test for ovarian reserve. Multiple dynamic and endocrine tests, such as basal FSH and estradiol, FSH/LH ratio, clomiphene citrate challenge test (CCCT), inhibin-B levels, anti-Müllerian hormone levels, GnRH agonist stimulation test (GAST) and exogenous FSH ovarian reserve test (EFORT), have been proposed (Scott and Hofmann, 1995
| The pattern of follicular distribution |
|---|
|
|
|---|
Lass et al. (1997b
The recent interest in ovarian tissue cryopreservation for cancer patients has opened the doors for the further investigation of the follicular distribution in the ovarian cortex in young women interested in ovarian cryopreservation before or after chemotherapy. Poirot et al. (2002
) collected ovarian tissue from 31 women (seven had half an ovary and 24 had a whole ovary removed), 19 of whom had between three and six courses of chemotherapy (13 had low doses of alkylating agents). They showed that the follicular distribution was again non-homogeneously distributed within the ovarian cortex and that the follicular pool declined with age. It was of interest that the investigators could not find a deleterious effect of prior chemotherapy on the mean follicular concentration (Poirot et al., 2002
).
Most recently, Schmidt et al. (2003
) consented 21 women with cancer (six of whom received prior chemotherapy) to have one or both ovaries cryopreserved; 17 had one ovary removed and four had ovarian biopsies. In addition, three of the 21 had both ovaries removed. For the first time, these investigators studied the follicular distribution in the whole ovarian cortex instead of a representative section. Confirming prior results, the investigators showed a significant inverse relationship between age and follicular density. Among the three women who had both ovaries removed, there was a huge variation in the number of primordial follicles between each fragment of the same ovary of several orders of magnitude. In one example, two follicles were found in one fragment and >2000 in another fragment from the same ovary. It was of interest that in all three ovaries, the primordial follicles tended to lie in clusters in the ovarian fragments rather than being evenly distributed throughout the tissue (Schmidt et al., 2003
).
| Conclusion |
|---|
|
|
|---|
There is good evidence currently that the follicular distribution in the ovarian cortex is extremely heterogeneous, which implies that an ovarian biopsy sample is not representative of the actual follicular pool, and therefore this invasive (and potentially harmful) test is unlikely to add any new information to the ovarian reserve tests currently in practice. While recent investigations point to the use of the antral follicle count as the most predictive test of ovarian reserve (Frattarelli et al., 2000
| References |
|---|
|
|
|---|
Bancsi LF, Broekmans FJM, Eijkemans MJC, de Jong FH, Habbema J and te Velde E (2002) Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 77,328336.[CrossRef][Web of Science][Medline]
Engmann L, Sladkevicius P, Argwal R et al. (1999) Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilisation treatment. Fertil Steril 71,2229.[CrossRef][Web of Science][Medline]
FrattarelliJL, Lauria-Costab DF, Miller BT, Bergh PA and Scott RT (2000) Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril 74,512517.[CrossRef][Web of Science][Medline]
Kohl J, Dittrich R, Siebzehnrubl E and Wildt L (2000) Determination of follicle numbers in human ovarian biopsiesa method for estimation of outcome of ovarian cryopreservation. Fertil Steril 74 Suppl 1,212.
Kwee J, Elting MW, Schats R, Bezemer PD, Lambalk CB and Schoemaker J (2003) Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod 18,14221427.
Lass A (2001) Assessment of ovarian reserveis there a role for ovarian biopsy? Hum Reprod 16,10551057.
Lass A, Skull J, McVeigh E, Margara R and Winston R (1997a) Measurement of ovarian volume by transvaginal sonography prior to human menopausal gonadotrophin hyperstimulation can predict poor response of infertile patients in an IVF programme. Hum Reprod 12,294297.
Lass A, Silye R, Abrams DC, Krausz T, Margara R and Winston RML (1997b) Follicular density in ovarian biopsy of infertile woman: a novel method to assess ovarian reserve. Hum Reprod 12,10281031.
Morris JL, Thyer AC, Soules MR and Klein NA (2002) Antral follicle count by transvaginal ultrasound is reflective of the actual primordial follicle pool. Fertil Steril 77, Suppl 1,S3.[Web of Science][Medline]
Poirot C, Vacher-Lavenu M-C, Helardot P, Guibert J, Brugieres L and Jouannet P (2002) Human ovarian cryopreservation: indications and feasibility. Hum Reprod 17,14471452
Qu J, Godin PA, Nisolle M and Donnez J (2000) Distribution and epidermal growth factor receptor expression of primordial follicles in human ovarian tissue before and after cryopreservation. Hum Reprod 15,302310.
Scheffer GJ, Broekmans FJM, Looman CWN, Blankenstein M, Fauser BCJM, deJong FH and teVelde ER (2003) The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18,700706.
Schmidt, KLT, Byskov A, Nyboe Andersen A, Muller J and Yding Andersen C (2003) Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod 18,11581164.
Scott RT and Hoffman GE (1995) Prognostic assessment of ovarian reserve. Fertil Steril 63,111.[Web of Science][Medline]
Sharara FI and McClamrock HD (1999) The effect of reproductive aging on ovarian volume measurements in infertile women. Obstet Gynecol 94,5760.[CrossRef][Web of Science][Medline]
Sharara FI, Scott RT, Jr and Seifer DB (1998) Contemporary investigation of ovarian reserve in infertile women. Am J Obstet Gynecol 179,804812.[CrossRef][Web of Science][Medline]
Tomas C, Nuojua-Huttunen S, Martikainen H et al. (1997) Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 12,220223.
VanRooij IAJ, Broekmans FJM, te Velde ER, Fauser BC, Bancsi LF, de Jong FH and Themmen APN (2002) Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17,30653071.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Lutchman Singh, M. Davies, and R. Chatterjee Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.B. Lambalk, C.H. de Koning, A. Flett, Y. van Kasteren, R. Gosden, and R. Homburg Assessment of ovarian reserve: Ovarian biopsy is not a valid method for the prediction of ovarian reserve Hum. Reprod., May 1, 2004; 19(5): 1055 - 1059. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

